PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A）
Clinical trial NCT07406139 · RECRUITING
Trial details
- NCT number
- NCT07406139
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2026-12-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.